Search results - 1 result
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
comparable to many surrounding countries. These adjusted prevalences can help estimate the cost of reimbursement of DAA s and invite Belgian policy makers to accelerate the scaling up of reimbursement, giving ...